# Sodium Polystyrene Sulfonate

NDC: 46287-006
Generic name: sodium polystyrene sulfonate
Labeler / Manufacturer: CMP Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL, RECTAL
Marketing started: 19821208

FDA application: ANDA087859

## Active ingredients

- SODIUM POLYSTYRENE SULFONATE: 15 g/60mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46287-006"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46287-006
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=12d48dcf-07bd-4b06-bd6c-7543f1be8357